Hypoxia-Activated PEGylated Conditional Aptamer/Antibody for Cancer Imaging with Improved Specificity
Fang Zhou(Kunming Medical University), Weihong Tan(Petronas (Malaysia)), Zilong Zhao(The University of Texas MD Anderson Cancer Center), Liuting Mo(Hunan University), Xiaohong Fang(Chinese Academy of Sciences), Honglin Liu(Zhongshan City Second People's Hospital), Qin Huang(Zunyi Medical University), Ting Fu(Salk Institute for Biological Studies), Dongmei Han(Dr. John T. Macdonald Foundation), Yongbo Peng(Chongqing Medical and Pharmaceutical College), Qianqian Wang(Southern University of Science and Technology), Hailan Kuai(Hunan University)
Cited by 112
Related Papers
Conjugation of Biomolecules with Luminophore-Doped Silica Nanoparticles for Photostable Biomarkers
|Analytical Chemistry|2001|748
Nanotechnology in Therapeutics: A Focus on Nanoparticles as A Drug Delivery System
|Nanomedicine|2012|609
Preparation and antibacterial activity of Fe<sub>3</sub>O<sub>4</sub>@Ag nanoparticles
|Nanotechnology|2007|600
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|597
Activatable Fluorescence/MRI Bimodal Platform for Tumor Cell Imaging via MnO<sub>2</sub> Nanosheet–Aptamer Nanoprobe
|Journal of the American Chemical Society|2014|585